- Home
- RPRX vs HUBB Comparison
RPRX vs HUBB Comparison
Compare RPRX & HUBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | HUBB |
|---|---|---|
| Founded | 1996 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.2B | 25.4B |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | RPRX | HUBB |
|---|---|---|
| Price | $55.69 | $479.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | $51.40 | ★ $517.88 |
| AVG Volume (30 Days) | ★ 3.2M | 559.7K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.90% | 1.04% |
| EPS Growth | N/A | ★ 15.10 |
| EPS | 0.67 | ★ 3.41 |
| Revenue | $2,378,193,000.00 | ★ $5,844,600,000.00 |
| Revenue This Year | $38.63 | $10.41 |
| Revenue Next Year | $4.73 | $5.49 |
| P/E Ratio | ★ $84.44 | $140.08 |
| Revenue Growth | ★ 5.06 | 3.84 |
| 52 Week Low | $34.63 | $403.82 |
| 52 Week High | $58.84 | $565.50 |
Technical Indicators
Market Signals| Indicator | RPRX | HUBB |
|---|---|---|
| Relative Strength Index (RSI) | 49.42 | 44.75 |
| Support Level | $38.07 | $462.25 |
| Resistance Level | $56.50 | $491.11 |
| Average True Range (ATR) | 1.32 | 15.01 |
| MACD | -0.14 | -3.61 |
| Stochastic Oscillator | 36.38 | 10.30 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About HUBB Hubbell Inc
Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, in electrical substations, and in commercial and industrial buildings. The company's primary operations are in the United States, where around 90% of revenue is derived.